Uroxatral

Treatment of Enlarged Prostate Symptoms

Uroxatral is primarily prescribed to manage the symptoms of benign prostatic hyperplasia (BPH). BPH is a common condition in older men where the prostate gland grows larger, which can put pressure on the urethra and interfere with normal urination.

This medication helps relieve several urinary issues associated with an enlarged prostate, including:

• Difficulty starting the flow of urine.
• A weak or interrupted urinary stream.
• Feeling that the bladder is not completely empty after urinating.
• A frequent or urgent need to urinate.
• Waking up often during the night to urinate (nocturia).

How It Works for BPH

While Uroxatral helps manage the symptoms of BPH, it is important to note that it does not physically shrink the size of the prostate. Instead, it works by relaxing the muscles in the prostate and the opening of the bladder. This relaxation makes it easier for urine to pass through the urethra, providing relief from obstructive symptoms.

Uroxatral is specifically indicated for use in men and is not intended for use in women or children.

Mechanism of Action

Uroxatral belongs to a group of medicines called alpha-blockers. It works by blocking specific receptors, known as alpha-1 receptors, found in the smooth muscle of the prostate and the opening of the bladder.

In men with benign prostatic hyperplasia (BPH), the prostate gland is enlarged and the muscles in the prostate and bladder neck can become tense. This tension puts pressure on the urethra, the tube that carries urine out of the body, making it difficult to urinate. Uroxatral helps these muscles relax, which leads to several improvements:

• Increased urine flow
• Less straining during urination
• Reduced feeling of incomplete bladder emptying

While this medication helps relieve the symptoms of an enlarged prostate by relaxing muscle tissue, it does not physically shrink the size of the prostate gland.

Common Side Effects

Some people may experience mild side effects while taking this medication. These often include:

• Dizziness or lightheadedness
• Headache
• Feeling tired or weak
• Stomach pain, nausea, or constipation
• Sore throat or runny nose

Serious Side Effects

While less common, some side effects can be serious. Seek medical attention immediately if you experience:

• Fainting: A sudden loss of consciousness, often occurring when standing up.
• Chest pain: New or worsening chest pain (angina).
• Priapism: A painful erection that lasts for four hours or longer. This is a medical emergency that requires immediate treatment to prevent permanent damage.
• Severe allergic reaction: Hives, skin rash, itching, or swelling of the face, tongue, or throat.
• Liver problems: Yellowing of the eyes or skin (jaundice), dark urine, or severe stomach pain.

If you are scheduled for eye surgery, such as for cataracts or glaucoma, tell your surgeon you are taking Uroxatral. The medication can cause a condition called Intraoperative Floppy Iris Syndrome (IFIS) during the procedure.

Blood Pressure and Fainting

Uroxatral can cause a sudden drop in blood pressure, especially when sitting up or standing from a lying position. This may lead to dizziness, lightheadedness, or fainting (syncope). These effects are most common when first starting the medication or when the dose is increased. It is generally advised to avoid driving or performing hazardous tasks until the individual knows how the medication affects them.

Liver and Kidney Health

This medication is processed by the liver and should not be used by individuals with moderate to severe liver impairment. Caution is also advised for those with severe kidney disease, as the drug may accumulate in the body.

Drug Interactions

Uroxatral should not be taken with potent CYP3A4 inhibitors, such as certain antifungal medications (ketoconazole, itraconazole) or HIV protease inhibitors (ritonavir). Combining these drugs can significantly increase the levels of Uroxatral in the blood, raising the risk of serious side effects.

Heart Rhythm Concerns

There is a potential risk for Uroxatral to affect the heart's electrical activity, known as QT prolongation. Caution is recommended for individuals with a history of heart rhythm problems or those taking other medications known to prolong the QT interval.

Cataract Surgery

Patients planning to undergo cataract or glaucoma surgery should inform their ophthalmologist if they are taking or have previously taken Uroxatral. The medication can cause a complication known as Intraoperative Floppy Iris Syndrome (IFIS) during the procedure.

Other Serious Warnings

• Priapism: Although rare, alpha-blockers like Uroxatral can cause a painful or prolonged erection lasting four hours or more. This requires immediate medical attention to prevent permanent tissue damage.
• Prostate Cancer: Because the symptoms of an enlarged prostate and prostate cancer are similar, healthcare providers typically rule out cancer before starting treatment with Uroxatral.

Pregnancy

Uroxatral is used to treat symptoms of an enlarged prostate in men and is not intended for use in women. Consequently, there are no adequate or well-controlled studies regarding its safety in pregnant women. In animal studies, no fetal harm was observed even at doses significantly higher than the recommended human dose.

Breastfeeding

It is unknown if Uroxatral is excreted in human breast milk. Because the drug is not approved for use in women, the potential effects on a nursing infant have not been studied. Individuals with concerns about medication exposure should speak with a healthcare provider.

Uroxatral is supplied in the following dosage form:

• Extended-release tablet: This is a long-acting oral formulation designed to release the medication slowly into the body. These tablets must be swallowed whole and should not be crushed, chewed, or broken.

FDA Approval Status

Uroxatral, the brand name for alfuzosin hydrochloride, is an FDA-approved medication. It was originally approved as an extended-release tablet to improve urination in men with enlarged prostates.

Approved Indications

The primary FDA-approved indication for Uroxatral is the treatment of the signs and symptoms of benign prostatic hyperplasia (BPH). It is not indicated for the treatment of hypertension (high blood pressure) and has not been approved for use in women or children.

Regulatory Safety Information

• Boxed Warnings: Uroxatral does not have any FDA boxed warnings, which are the most serious warnings issued by the FDA.
• REMS: There is no Risk Evaluation and Mitigation Strategy (REMS) required for this medication.
• Controlled Substance: Uroxatral is not a controlled substance.
• Contraindications: The FDA-approved labeling includes contraindications for patients with moderate to severe liver impairment and for those taking certain medications that inhibit the CYP3A4 enzyme, as these can significantly increase drug levels in the body.

Generic Availability

Uroxatral is available as a generic medication called alfuzosin. Generic drugs contain the same active ingredients and are just as effective as brand-name drugs, but they are typically available at a much lower price.

Insurance Coverage

Most insurance plans, including Medicare Part D, cover the generic version of this medication. Brand-name Uroxatral may not be covered by all plans, or it may require a higher copayment or prior authorization from a healthcare provider.

Factors Influencing Price

Several factors can affect the final price of the medication:

• Pharmacy Choice: Prices can vary significantly between different retail pharmacies and mail-order services.
• Quantity: Buying a larger supply, such as a 90-day prescription, may sometimes reduce the cost per dose compared to a 30-day supply.
• Savings Programs: Some patients may be eligible for manufacturer coupons or pharmacy discount cards that can reduce out-of-pocket expenses.

If the cost of Uroxatral is a concern, you should speak with your pharmacist or healthcare provider about the availability of lower-cost generic alternatives.